Development of Oral Controlled Release Tablet Formulations Based on Diltiazem–Carrageenan Complex
- 1 January 2004
- journal article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 9 (2) , 155-162
- https://doi.org/10.1081/pdt-120027428
Abstract
(2004). Development of Oral Controlled Release Tablet Formulations Based on Diltiazem–Carrageenan Complex. Pharmaceutical Development and Technology: Vol. 9, No. 2, pp. 155-162.Keywords
This publication has 17 references indexed in Scilit:
- Effect of anionic polymers on the release of propranolol hydrochloride from matrix tabletsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tabletsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999
- Matrix Tablets of Carrageenans. II. Release Behavior And Effect of Added CationsDrug Development and Industrial Pharmacy, 1999
- On the employment of λ carrageenan in a matrix system. III. Optimization of a λ carrageenan–HPMC hydrophilic matrixJournal of Controlled Release, 1998
- Controlled-Release Tablet Matrices from Carrageenans: Compression and Dissolution StudiesPharmaceutical Development and Technology, 1997
- Optimization of Sustained-Release Tablet Formulations: a Four-Component Mixture ExperimentPharmaceutical Development and Technology, 1997
- On the employment of λ-carrageenan in a matrix system. II. λ-Carrageenan and hydroxypropylmethylcellulose mixturesJournal of Controlled Release, 1994
- On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gumJournal of Controlled Release, 1993
- The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matricesInternational Journal of Pharmaceutics, 1988
- Interaction of Antihistamines with HydrocolloidsJournal of Pharmaceutical Sciences, 1963